NCT01078337View on ClinicalTrials.gov

T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Leukemia, Lymphocytic, Acute
Interventions
PROCEDURE

bone marrow aspiration

PROCEDURE

peripheral blood sampling

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01078337 - T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis | Biotech Hunter | Biotech Hunter